Association between de Quervain syndrome and herpes zoster: a population-based cohort study

Hsu, Chao‐Yu; Ke, Der-Shin; Lin, Cheng‐Li; Kao, Chia‐Hung

doi:10.1136/bmjopen-2020-046891

Cited by 11 publications

(4 citation statements)

References 28 publications

(27 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…17 Disease prevalence is high in women with approximately 1.3% of the population afflicted, in comparison with 0.5% in men. 18 The disease is commonly associated with chronic overuse of the wrist and is related to the following risk factors: age (between 30 and 50), sex (more common in women), pregnancy, postpartum care of newborn, and jobs or activities that involve constant use of the wrist. 19 Most common nonsurgical treatments are behavioural modifications, NSAIDs, thumb spica splinting and transcutaneous steroid injections into the first dorsal compartment.…”

Section: Discussionmentioning

confidence: 99%

Unblinding de Quervain: A systematic review of ultrasound‐guided injection of corticosteroids for treatment of stenosing tenosynovitis of the 1st extensor compartment

Cheah

et al. 2023

J of Medical Radiation Sci

View full text Add to dashboard Cite

A systematic review was conducted on studies reporting steroid injections with ultrasound for de Quervain. From 10 studies included and 379 wrists, 73.9% reported complete resolution of symptoms, 18.2% with partial and 7.9% without resolution. When compared to the landmark‐guided technique, ultrasound guidance showed significantly higher rates of symptom resolution (P = 0.0132) and lower pain scores (P < 0.0001). Twenty‐nine patients out of 163 who initially showed complete resolution of symptoms reported subsequent recurrence. We conclude that steroid injections guided by ultrasound present high rates of symptomatic relief through precise needle insertion, especially in cases of anatomic variability with subcompartments.

show abstract

Section: Discussionmentioning

confidence: 99%

Unblinding de Quervain: A systematic review of ultrasound‐guided injection of corticosteroids for treatment of stenosing tenosynovitis of the 1st extensor compartment

Cheah

et al. 2023

J of Medical Radiation Sci

View full text Add to dashboard Cite

show abstract

“…The reactivation of VZV can be caused by stress [7]. Stress from musculoskeletal-related [8][9][10][11] and urogenitalrelated [12][13][14] chronic pain and endocrine-related diseases [15] have been identified as being associated with HZ development. Pulmonary TB may be a stressor for infected individuals and may lead to the development of HZ.…”

Section: Introductionmentioning

confidence: 99%

Risk of Herpes Zoster in Patients with Pulmonary Tuberculosis—A Population-Based Cohort Study

Wang

Chen

Hsieh

et al. 2023

IJERPH

Self Cite

View full text Add to dashboard Cite

Background: Pulmonary tuberculosis (TB), a global health problem, is typically caused by the bacterium Mycobacterium tuberculosis. Herpes zoster (HZ) is caused by the reactivation of the varicella-zoster virus (VZV). The reactivation of VZV can be caused by stress. We investigated whether pulmonary TB increases the risk of HZ development. Methods: This study used data that sampled a population of 2 million people in 2000 from the National Health Insurance Research Database. This cohort study observed Taiwanese patients aged 20–100 years with pulmonary TB from 2000 to 2017 (tracked to 2018). Pulmonary TB was defined as having two or more outpatient diagnoses or at least one admission record. To address potential bias caused by confounding factors, the control cohort and pulmonary TB cohort were matched 1:1 by age, gender, index year, and comorbidities. Patients with HZ before the index date were excluded. Results: A total of 30,805 patients were in the pulmonary TB and control cohorts. The incidence rate of HZ in pulmonary TB and control cohorts were 12.00 and 9.66 per 1000 person-years, respectively. The risk of HZ in the pulmonary TB cohort (adjusted hazard ratios = 1.23; 95% confidence interval = 1.16–1.30) was significantly higher than that of in control cohort. Among patients without comorbidities, the patients with TB were 1.28-fold more likely to have HZ than those without TB. Conclusion: Patients with TB should be well treated to avoid the potential risk of HZ occurrence. Although we identified the association between pulmonary TB and HZ, further studies are needed to confirm the result.

show abstract

“…The HZ vaccine may be administrated to high-risk individuals [ 5 ]. Stress caused by physical illness may induce the reactivation of VZV leading to HZ [ 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 ]. Liao et al and Choi et al have reported that psychological diseases, such as depression, also increase the risk of HZ [ 14 , 15 ].…”

Section: Introductionmentioning

confidence: 99%

The Risk of Herpes Zoster in Women with Polycystic Ovary Syndrome: A Retrospective Population-Based Study

Hsieh

Chen

Cheng

et al. 2022

IJERPH

Self Cite

View full text Add to dashboard Cite

Background: The association between polycystic ovary syndrome (PCOS) and the risk of herpes zoster (HZ) remains unclear. This study investigated the risk of HZ in women with PCOS. Methods: This study used data from the Longitudinal Generation Tracking Database (LGTD 2005) which contains the information of 2 million randomly selected from National Health Insurance beneficiaries. Patients who received a diagnosis of PCOS between 2000 and 2017 were included in the PCOS cohort. Patients who were not diagnosed as having PCOS were randomly selected from the LGTD 2005 and included in the control cohort. Patients who were aged <20 years and had a history of HZ before the index date were excluded. Patients who were in both the cohorts were matched at a ratio of 1:1 through propensity score matching based on age, comorbidities, and medication. The primary outcome was the diagnosis of HZ. Results: A total of 20,142 patients were included in each case and control cohorts. The incidence rates of HZ in the PCOS and control cohorts were 3.92 and 3.17 per 1000 person-years, respectively. The PCOS cohort had a significantly higher risk of HZ than did the control cohort (adjusted hazard ratios [aHR] = 1.26). Among the patients aged 30–39 years, those with PCOS had a significantly higher risk of HZ than did those without PCOS (aHR = 1.31). Among the patients without any comorbidities, those with PCOS had a significantly higher risk of HZ (aHR = 1.26) than did those without PCOS. Conclusion: PCOS is associated with the risk of HZ, especially in young women. The risk of HZ should be addressed while treating patients with PCOS. An HZ vaccine is recommended for these patients.

show abstract

Association between de Quervain syndrome and herpes zoster: a population-based cohort study

Cited by 11 publications

References 28 publications

Unblinding de Quervain: A systematic review of ultrasound‐guided injection of corticosteroids for treatment of stenosing tenosynovitis of the 1st extensor compartment

Unblinding de Quervain: A systematic review of ultrasound‐guided injection of corticosteroids for treatment of stenosing tenosynovitis of the 1st extensor compartment

Risk of Herpes Zoster in Patients with Pulmonary Tuberculosis—A Population-Based Cohort Study

The Risk of Herpes Zoster in Women with Polycystic Ovary Syndrome: A Retrospective Population-Based Study

Contact Info

Product

Resources

About